{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:17:47Z","timestamp":1790533067913,"version":"4.1.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1097\/01.mjt.0000434043.62372.00","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T09:15:31Z","timestamp":1385025331000},"page":"e714-e719","source":"Crossref","is-referenced-by-count":17,"title":["Hepatotoxicity in Obese Versus Nonobese Patients With Acetaminophen Poisoning Who Are Treated With Intravenous N-Acetylcysteine"],"prefix":"10.1097","volume":"23","author":[{"given":"John J.","family":"Radosevich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asad E.","family":"Patanwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Erstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-10-20210202","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1093\/ajhp\/59.21.2105","article-title":"Which weight for weight-based dosage regimens in obese patients?","volume":"59","author":"Erstad","year":"2002","journal-title":"Am J Health-Syst Pharm"},{"key":"R3-10-20210202","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00134-003-2059-6","article-title":"Dosing medications in morbidly obese patients in the intensive care unit setting","volume":"30","author":"Erstad","year":"2004","journal-title":"Intensive Care Med"},{"key":"R4-10-20210202","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1097\/CCM.0b013e3182411720","article-title":"Obesity in critical illness: what weight or why weight?","volume":"40","author":"Erstad","year":"2012","journal-title":"Crit Care Med"},{"key":"R5-10-20210202","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.2146\/ajhp100226","article-title":"Availability of information for dosing injectable medications in underweight or obese patients","volume":"67","author":"Jacques","year":"2010","journal-title":"Am J Health Syst Pharm"},{"key":"R6-10-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/js980173a","article-title":"Pharmacokinetic considerations in obesity","volume":"88","author":"Blouin","year":"1999","journal-title":"J Pharm Sci"},{"key":"R7-10-20210202","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0022-5347(25)00230-7","article-title":"Obesity as a risk factor in drug-induced organ injury: increased liver and kidney damage by acetaminophen in the obese overfed rat","volume":"241","author":"Corcoran","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"R8-10-20210202","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.3748\/wjg.v12.i14.2217","article-title":"Estimating liver weights in adults by body weight and gender","volume":"12","author":"Chan","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R9-10-20210202","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s00261-003-0139-2","article-title":"Normal organ volume assessment from abdominal CT","volume":"29","author":"Geraghty","year":"2004","journal-title":"Abdom Imaging"},{"key":"R10-10-20210202","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/sj.ijo.0802526","article-title":"Effect of organ and tissue masses on resting energy expenditure in underweight, normal weight and obese adults","volume":"28","author":"Bosy-Westphal","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R13-10-20210202","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198812153192401","article-title":"Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985)","volume":"319","author":"Smilkstein","year":"1988","journal-title":"N Engl J Med"},{"key":"R14-10-20210202","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/archinte.1981.00340030118021","article-title":"Treatment of severe acetaminophen poisoning with intravenous acetylcysteine","volume":"141","author":"Prescott","year":"1981","journal-title":"Arch Intern Med"},{"key":"R15-10-20210202","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1210\/jc.2008-1399","article-title":"Obesity-associated liver disease","volume":"93","author":"Marchesini","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R16-10-20210202","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/138920011794520035","article-title":"Does hepatic steatosis affect drug metabolism enzymes in the liver?","volume":"12","author":"Buechler","year":"2011","journal-title":"Curr Drug Metab"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.mjt.0000434043.62372.00","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T22:39:55Z","timestamp":1746052795000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201605000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mjt.0000434043.62372.00","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}